Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSV Vaccination in Lung Transplant Recipients
NCT07895394Phase 4Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 4 trial of GSK3003899A in respiratory syncytial virus infection (RSV), sponsored by Seoul National University Hospital. Started Oct 2026; status: recruiting.
02
Drugs
GSK3003899A
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT07895394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07895394.